RBF Capital’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
– Sell
-8,000
Closed -$646K – 567
2022
Q3
$646K Hold
8,000
– – 0.05% 290
2022
Q2
$718K Sell
8,000
-7,000
-47% -$709K 0.05% 295
2022
Q1
$1.67M Hold
15,000
– – 0.11% 206
2021
Q4
$1.55M Buy
+15,000
New +$1.74M 0.1% 208
2016
Q4
– Sell
-3,000
Closed -$259K – 383
2016
Q3
$259K Hold
3,000
– – 0.04% 258
2016
Q2
$260K Hold
3,000
– – 0.05% 251
2016
Q1
$225K Sell
3,000
-3,000
-50% -$226K 0.04% 275
2015
Q4
$462K Buy
+6,000
New +$452K 0.09% 205

Other funds holding MDT

RBF Capital's MDT Position: Q4 2022 in Review

RBF Capital sold out of Medtronic (MDT) in Q4 2022, closing a stake of 8,000 shares — an estimated $646K sold.

RBF Capital first reported a position in MDT in Q4 2015 and held it in 8 quarters. The position peaked at $1.67M in Q1 2022. 1,961 funds tracked by Wall St. Rank hold MDT as of Q4 2022.

  • RBF Capital reported no remaining Medtronic position as of Q4 2022 after selling out during the quarter.
  • RBF Capital sold 8,000 Medtronic shares in Q4 2022, an estimated $646K.
  • RBF Capital first reported a position in Medtronic in Q4 2015 and held it in 8 quarters.
  • RBF Capital's Medtronic position peaked at $1.67M in Q1 2022.
  • 1,961 funds tracked by Wall St. Rank held Medtronic as of Q4 2022.

Based on RBF Capital's 13F filing for Q4 2022, filed 14 Feb 2023.